Form 8-K - Current report:
SEC Accession No. 0001193125-25-125763
Filing Date
2025-05-23
Accepted
2025-05-23 14:21:38
Documents
13
Period of Report
2025-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d908097d8k.htm   iXBRL 8-K 33752
  Complete submission text file 0001193125-25-125763.txt   187122

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20250521.xsd EX-101.SCH 4248
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20250521_def.xml EX-101.DEF 13886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20250521_lab.xml EX-101.LAB 23297
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20250521_pre.xml EX-101.PRE 14854
15 EXTRACTED XBRL INSTANCE DOCUMENT d908097d8k_htm.xml XML 6202
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 25981312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)